Skip to main content
Clinical Trials/IRCT20190712044182N1
IRCT20190712044182N1
Recruiting
Phase 3

The effects of arginine supplementation on clinical symptoms, quality of life and anal internal sphincter pressure in patients with chronic anal fissure

Iran University of Medical Sciences0 sites76 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 3
Status
Recruiting
Enrollment
76

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Chronic Anal Fischer
  • Fisher in the posterior and anterior areas of the anus
  • Non\-pregnant and lactating women
  • Age: 18 \- 65 years
  • BMI: 18\.5 \- 35 kg/m2
  • Non\-specific digestive diseases such as Crohn's disease, Ulcerative colitis, gastrointestinal cancers and etc.
  • The absence of diseases that fissure can be their complications: tuberculosis, AIDS, syphilis, herpes, leukemia and etc.
  • No history of malignancy or malignancy in present
  • No history of heart disease
  • No history of fissure and hemorrhoid surgery

Exclusion Criteria

  • Not provided

Investigators

Similar Trials